Figure 1From: HER2 Amplification Has no Prognostic Value in Sporadic and Hereditary Ovarian TumoursKaplan-Meier survival curves for 53 patients with ovarian cancer with HER2 amplification in the tumour tissue (group 1, n = 10) versus patients demonstrating no HER2 amplification (group 2, n = 43). The difference was not significant by the log-rank test (p = 0.33)Back to article page